Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of identifying HIV patients sensitive to therapy with GP120 V3 glycan-directed antibodies

Methods of identifying HIV patients sensitive to therapy with GP120 V3 glycan-directed antibodies

US Patent 12102677 · Granted Oct 1, 2024

Estimated economic value: $337,572,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies that target HIV gp120 and methods of use2025
Multi-specific antigen binding molecules targeting HIV and methods of use2025
Engineering pH-dependent antigen binding activity into anti-HIV antibodies with 2024
Human immunodeficiency virus neutralizing antibodies2023
Multispecific antibodies that target HIV GP120 and CD32023
Antibodies that target HIV GP120 and methods of use2021
Human immunodeficiency virus neutralizing antibodies2021
Human immunodeficiency virus neutralizing antibodies2019
Fusion antibodies for HIV therapy2014
Pig whose genome comprises a heterologous site-specific recombination site and a2013